Neuralstem, Inc. (AMEX: CUR)

Neuralstem, Inc. (AMEX: CUR), a publicly traded biotherapeutics company, is focused on applying stem cell research and its patented human neural stem cell technology to treat diseases of the central nervous system. The company’s patent-protected technology allows them to produce mature, commercial quantities of neural stem cells that have the capability to control the differentiation of the cells into physiologically relevant human neurons and glia. For further information, visit the Company’s web site at www.neuralstem.com.